Compounds > bathocuproine disulfonate
Page last updated: 2024-09-05

bathocuproine disulfonate and neocuproine

bathocuproine disulfonate has been researched along with neocuproine in 6 studies

Compound Research Comparison

Studies
(bathocuproine disulfonate)		Trials
(bathocuproine disulfonate)		Recent Studies (post-2010)
(bathocuproine disulfonate)		Studies
(neocuproine)		Trials
(neocuproine)		Recent Studies (post-2010) (neocuproine)
103025167051

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chevion, M; Zhu, BZ1
Gal, S; Lichtenberg, D; Pinchuk, I1
Ast, G; Malca, H; Shomron, N; Vig, I1
Chen, SH; Liang, YC; Lin, JK; Lin-Shiau, SY; Liu, SH1
Apak, R; Çelik, SE; Güçlü, K; Ozyürek, M1
Apak, R; Güçlü, K; Kondakçı, E; Özyürek, M1

Other Studies

6 other study(ies) available for bathocuproine disulfonate and neocuproine

ArticleYear
Copper-mediated toxicity of 2,4,5-trichlorophenol: biphasic effect of the copper(I)-specific chelator neocuproine.
    Archives of biochemistry and biophysics, 2000, Aug-15, Volume: 380, Issue:2

    Topics: Catalase; Chelating Agents; Chlorophenols; Copper; Dimethyl Sulfoxide; Drug Interactions; Escherichia coli; Ethanol; Free Radical Scavengers; Oxidation-Reduction; Phenanthrolines; Superoxide Dismutase

2000
The dose-dependent effect of copper-chelating agents on the kinetics of peroxidation of low-density lipoprotein (LDL).
    Free radical research, 2001, Volume: 34, Issue:4

    Topics: Chelating Agents; Copper; Dose-Response Relationship, Drug; Free Radical Scavengers; Free Radicals; Humans; Kinetics; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Phenanthrolines

2001
Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.
    Nucleic acids research, 2002, Oct-01, Volume: 30, Issue:19

    Topics: Chelating Agents; Copper; Dose-Response Relationship, Drug; HeLa Cells; Humans; Phenanthrolines; RNA Splicing; RNA, Messenger; RNA, Small Nuclear; Spliceosomes; Zinc

2002
Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 102, Issue:1

    Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Caspase 3; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chelating Agents; Copper; Cytochromes c; DNA Breaks; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Glutathione; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phenanthrolines; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Time Factors

2008
Differences in responsivity of original cupric reducing antioxidant capacity and cupric-bathocuproine sulfonate assays to antioxidant compounds.
    Analytical biochemistry, 2012, Apr-01, Volume: 423, Issue:1

    Topics: Antioxidants; beta Carotene; Chelating Agents; Copper; Humans; Oxidation-Reduction; Phenanthrolines; Spectrophotometry, Ultraviolet

2012
Novel pro-oxidant activity assay for polyphenols, vitamins C and E using a modified CUPRAC method.
    Talanta, 2013, Oct-15, Volume: 115

    Topics: Acetates; Antioxidants; Ascorbic Acid; Biological Assay; Calibration; Cations, Divalent; Cations, Monovalent; Copper; Egg Proteins; Oxidation-Reduction; Phenanthrolines; Plant Extracts; Polyphenols; Protein Carbonylation; Sensitivity and Specificity; Solutions; Sulfhydryl Compounds; Vitamin E

2013